Home › NDC Lookup › Ingredients › Camphor Menthol › 59321-0055-01
ZHENG GU SHUI CAMPHOR, MENTHOL 5.6 g/100mL; 5.6 g/100mL Liniment, 100 mL — NDC 59321-0055-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

ZHENG GU SHUI CAMPHOR, MENTHOL 5.6 g/100mL; 5.6 g/100mL Liniment, 100 mL — NDC 59321-055-01 (Billing 59321-0055-01)

by GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD · 100 mL in 1 BOTTLE

This is a package of 100 mL of ZHENG GU SHUI CAMPHOR, MENTHOL 5.6 g/100mL; 5.6 g/100mL Liniment from GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD, marketed since Jun 2025 and currently FDA-listed, this package's marketing is listed to end Jun 2030. It is the main listing for this product, which comes in 5 package sizes.

NDC 59321-0055-01
🏷️ FDA NDC (as labeled) 59321-055-01 billing pads the product segment with a zero
This package
Contains100 mL Pack sizes5 compare ↓
Main listing for product 59321-055 · Also comes in: 12 ml 59321-055-05 30 ml 59321-055-04 60 ml 59321-055-03 88 ml 59321-055-02
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 59321-055-01
Product NDC 59321-055
11-digit billing NDC 59321005501
RxCUI 1366315
UNII 5TJD82A1ET, L7T10EIP3A
Application # M017
SPL Set ID 17552943-4f11-42d6-ad41-fbc53f2bbd9a
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-06-01
Marketing end 2030-06-01
Route PERCUTANEOUS, TRANSDERMAL
Dosage form LINIMENT
Substance CAMPHOR (SYNTHETIC); MENTHOL
Quick answers
  • RxCUI (RxNorm): 1366315
Why two NDCs? The FDA registers this code as 59321-055-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 59321-0055-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Zheng Gu Shui is a topical liniment containing camphor and menthol that is applied directly to the skin. Both ingredients are commonly used in over-the-counter products for localized discomfort and muscle tension. This is an OTC monograph drug, meaning it is marketed under established FDA guidelines for liniments in its category rather than through individual product approval. The liniment is intended for external use only.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 12 ml 30 ml 60 ml 88 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
59321-0055-01 You're viewing this Main listing 100 mL in 1 BOTTLE 2000-10-19 Jun 1, 2030 Active
59321-0055-02 59321-055-02 88 mL in 1 BOTTLE, WITH APPLICATOR 2000-10-19 Jun 1, 2030 Active
59321-0055-03 59321-055-03 60 mL in 1 BOTTLE, SPRAY 2000-10-19 Jun 1, 2030 Active
59321-0055-04 59321-055-04 30 mL in 1 BOTTLE 2000-10-19 Jun 1, 2030 Active
59321-0055-05 59321-055-05 12 mL in 1 BOTTLE Sample 2017-12-13 Jun 1, 2030 Active

You're viewing the largest of 5 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This package contains 100 mL — 100 ml in 1 bottle.
How does this package differ from NDC 59321-0055-05?
Both are ZHENG GU SHUI CAMPHOR, MENTHOL 5.6 g/100mL; 5.6 g/100mL Liniment — the drug itself is identical. This page's package is the 100 mL one, while NDC 59321-0055-05 is the 12 ml package.
What NDC number is used to bill for this package of ZHENG GU SHUI CAMPHOR, MENTHOL 5.6 g/100mL; 5.6 g/100mL Liniment?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Zheng Gu Shui 5.6 g/100mL; 5.6 g/100mLthis 59321-0055-01 GUANGXI 100 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Jun 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGUANGXI YULIN PHARMACEUTICAL GROUP CO LTD
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code59321
First marketedJun 2025
Product typeHuman Otc Drug
Portfolio2 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 27 words ▾

Uses For the temporary relief of minor aches and pains of muscles and joints due to: ■ arthritis ■ strains ■ bruises ■ sprains ■ simple backache

⏱️ Dosage and Administration 37 words ▾

Directions ■ Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. ■ Children under 2 years of age: do no use or consult a doctor.

⚠️ Warnings 12 words ▾

Warnings For external use only Flammable Keep away from fire or flame

🤒 Adverse Reactions 16 words ▾

Report any unexpected side effects from the use of this product to the FDA MedWatch Program.

📦 Storage and Handling 15 words ▾

Other information ■ keep container tightly closed ■ store at room temperature under 86°F (30°C)

🧪 Active Ingredient 6 words ▾

Active Ingredients Camphor 5.6% Menthol 5.6%

🧪 Inactive Ingredients 30 words ▾

Inactive Ingredients Alcohol, Japanese knotweed (Polygonum cuspidatum Siebold & Zucc.) rhizome, paniculate swallowwort [Pycnostelma paniculatum (Bge.) K. Schum.] root, shin-leaf prickly ash [Zanthoxylum nitidum (Roxb.) DC.] root, water, zedoary rhizome.

🎯 Purpose 5 words ▾

Purpose External Analgesic External Analgesic

📄 When Using This Product 18 words ▾

When using this product ■ avoid contact with the eyes or mucous membranes ■ do not bandage tightly

📄 Stop Use and Ask a Doctor If 71 words ▾

Stop use and ask a doctor if ■ condition worsens symptoms persist for more than 7 days ■ symptoms clear up and occur again within a few days ■ excessive irritation develops ■ nausea, vomiting, abdominal discomfort, diarrhea, or skin rash occurs ■ when using for pain of arthritis: ■ pain persists for more than 10 days ■ redness is present ■ in conditions affecting children under 12 years of age

📄 Keep Out of Reach of Children 23 words ▾

Keep out of reach of children to avoid accidental poisoning. If swallowed, get medical hep or contact a Poison Control Center right away.

📄 Questions or Comments 11 words ▾

Questions or Comments? (888) 221-3496 M-F 9 am to 5 pm

📄 Package Label / Principal Display Panel 16 words ▾

ZHENG GU SHUI NDC 59321-055-01 EXTERNAL ANALGESIC LOTION

3.4 FL OZ (100 mL) IMAGE OF CARTON

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for ZHENG GU SHUI (this brand).

Top reported reactions

Peripheral Motor Neuropathy2
Agitation1
Drug Abuse1
Dry Mouth1
Dyspnoea1
International Normalised Ratio Increased1
Multiple Organ Dysfunction Syndrome1

Reporter sex

8 reports

Serious outcomes

Hospitalization4
Death1
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD has reported a marketing end date of 2030-06-01, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 12 ml (59321-0055-05), 30 ml (59321-0055-04), 60 ml (59321-0055-03). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.